External Quality Control of ER, PR, and HER2 Immunohistochemistry and Continued Need for Optimization
13 Dec 2012

Breast pathology routinely employs immunohistochemistry for the classification and subsequent selection of patients for specific therapies. However, correct interpretation, is dependent on the quality of the staining produced, which can vary enormously between laboratories, and in some instanced show day-to-day variation within the same laboratory. Therefore, it is vital that laboratories not only use standardized staining procedures for ER,PR and HER2 immunohistochemistry but also optimize protocols as required.

Leica Microsystems



Show    per page
1 of 10 Page     1 2 3  ... Next 
A new approach to improving early characterization of therapeutic formulations - Viscosizer 2005 Sep 2014Read
An introduction to capillary rheometry - Evaluating material properties under process relevant conditions5 Sep 2014Read
Speed your way though your protein formulation screening by automating your measurements5 Sep 2014Read
Novel analytical technologies for product deformulation - Part 25 Sep 2014Read
Water treatment - Optimize coagulant dosing using zeta potential5 Sep 2014Read
Applications of rheology in the waxes, creams and emulsions arena5 Sep 2014Read
Avoiding Bottlenecks When Validating Your Laboratory Instrument and Information Systems20 Aug 2014Read
A New Concept in Metabolic Studies: How Personalized 'Sportomics' Bridges Bench and Clinical Science24 Jul 2014Read
Process development and optimisation using ambr250™ for mammalian and microbial processes2 Jul 2014Read
Why does ice cream taste smooth or gritty? It depends on the rheology!30 Jun 2014Read